(Q68205515)

English

Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: identification of transforming growth factor-beta as a suppressive factor

scientific article published on 01 January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: identification of transforming growth factor-beta as a suppressive factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

ovarian carcinoma

1 reference

based on heuristic

inferred from title

author name string

H Hirte

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

D A Clark

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

296-302

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

https://scigraph.springernature.com/pub.10.1007/bf01789047

0 references

Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer lymphocytes: evidence for regulation of induction and function by multiple cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of tumor growth on host defenses

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased secretion of type beta transforming growth factor accompanies viral transformation of cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The regulatory effect of adherent cells on lymphokine activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of lymphokine-activated killer induction by neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of proliferation in LAK cell development

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motility and tumoricidal activity of interleukin-2-stimulated lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the cells that suppress the cytotoxic activity of T lymphocytes. II. Physical properties, specificity, and developmental kinetics of the inhibitory splenic non-T cell population

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive acidic protein in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive factors in ascites fluids from ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1998971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01789047

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1998971%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68205515&oldid=1984014639"